Changes in Beneficial Ownership · 4
Biogen Inc.
BIIBNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-08-03
- Issuer
- BIOGEN INC.
- Issuer CIK
- 0000875045
- Trading symbol
- BIIB
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Minor Lloyd
- Reporting owner CIK
- 0002038687
- Relationship
- Director
- Address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-03 | S · Form 4 | 593 | D | 203.34 | 3,282 | D |
| Common Stock | 2026-08-04 | S · Form 4 | 593 | D | 200.96 | 2,689 | D |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Direct
Signature 1
- Signed
- /s/ Wendell Taylor, attorney-in-fact for Dr. Minor
- Date
- 2026-08-05
Company context
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media - Facebook, Instagram, LinkedIn, X, YouTube.